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ABSTRACT
Objective: This literature review summarizes current research and evidence regarding 
transgender persons and oral health. Methods: A search of the literature was 
conducted in the following databases: PubMed, Google Scholar, EBSCO Host, Science 
Direct, and Wiley Online Library using the keywords “transgender identity, gender 
non-conforming, discrimination, transition, binary systems, transgender oral cavity, 
transgender, transgender oral health, transgender dental health.” Articles published 
from 2000 to 2017 in both peer-reviewed and non-peer reviewed journals, which reported information regarding the oral health status of 
transgender populations, were selected for review. Results: The search revealed 18 articles, only 3 of which pertained to the oral health status of 
transgender client populations. Five other articles were eliminated due to either poor quality or irrelevance. Discussion: The 13 articles included in 
the review revealed a need for oral health care professionals to be aware that gender is not binary, nor is it a mental health disorder. Transgender 
people face heightened risk of discrimination, violence, anxiety, depression, suicidality, substance abuse, and sexually transmitted diseases, as 
well as significant barriers to health care of which oral health professionals should be made aware. Conclusions: Transgender people have the 
same rights as everyone else to oral health care. Oral health care providers are responsible for ensuring that transgender clients receive care 
that aligns with their needs and for providing that care in a culturally competent manner. This requires an understanding of the basics of gender 
nonconformance and its impact on oral–systemic health. Additional research is needed to increase the scientific knowledge base to facilitate 
improved health outcomes for this client population.
RÉSUMÉ
Objectif : Cette analyse documentaire résume la recherche actuelle et les données probantes à l’égard des personnes transgenres et la santé 
buccodentaire. Méthodologie : Une recherche documentaire a été menée dans les bases de données suivantes : PubMed, Google Scholar, EBSCO 
Host, Science Direct et Wiley Online Library au moyen des mots clés anglais « transgender identity (identité transgenre), gender non-conforming 
(genre non conforme), discrimination (discrimination), transition (transition), binary systems (systèmes binaires), transgender oral cavity (cavité 
buccale du transgenre), transgender (transgenre), transgender oral health (santé buccodentaire du transgenre), transgender dental health (santé 
dentaire du transgenre) ». Des articles de journaux, publiés de 2000 à 2017 dans des journaux évalués par les pairs et non évalués par les pairs, 
qui ont fourni de l’information sur l’état de santé buccodentaire des populations transgenres, ont été sélectionnés pour être évalués. Résultats : 
La recherche a montré que sur les 18 articles retenus, seulement 3 se rapportaient à l’état de santé buccodentaire des populations de clients 
transgenres. Cinq autres articles ont été éliminés en raison de leur mauvaise qualité ou de leur manque de pertinence. Discussion : Les 13 articles 
qui ont fait partie de l’évaluation ont révélé le besoin de sensibiliser les professionnels de la santé buccodentaire au fait que le genre n’est ni 
binaire ni un trouble de la santé mentale. Les transgenres font face à un risque plus élevé de discrimination, de violence, d’anxiété, de dépression, 
de tendances suicidaires, d’abus de substances et de maladies transmises sexuellement, ainsi qu’à d’importantes barrières aux soins de santé, pour 
lesquels les professionnels de la santé buccodentaire devraient être sensibilisés. Conclusions : Les personnes transgenres ont les mêmes droits 
aux soins de santé buccodentaire que les autres. Les prestataires de soins de santé buccodentaire sont responsables de veiller à ce que les clients 
transgenres reçoivent des soins qui s’alignent avec leurs besoins et de fournir ces soins d’une façon culturellement compétente. Cela exige une 
compréhension des notions fondamentales sur la non-conformité du genre et de ses effets sur la santé buccodentaire et physique. De la recherche 
supplémentaire est nécessaire afin d’augmenter la base de connaissances scientifiques et de favoriser l’amélioration des résultats de santé de 
cette population de clients. 
Keywords: binary systems, discrimination, gender nonconforming, transgender, transgender dental health, transgender identity, transgender oral 
cavity, transgender oral health, transition
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WHY THIS ARTICLE IS IMPORTANT TO 
DENTAL HYGIENISTS
• Oral health care providers are responsible 
for ensuring that all clients receive care 
that aligns with their needs.
• The oral health of transgender clients 
may be negatively affected by stress, 
discrimination, substance use, STDs, and 
hormone therapy.
• Knowledge of the experiences and health 
challenges of transgender persons will 
encourage the delivery of culturally 
competent care.
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NARRATIVE REVIEW
INTRODUCTION
There are approximately 1.4 million transgender adults 
in the United States, representing 0.6% of the population. 
They are a very diverse group, with 55% identifying as 
Causcasian, 16% as African-American or Black, 21% as 
Latino or Hispanic, and 8% as another race or ethnicity.1,2 
This diversity reflects that of the general population as 
reported by the US Census: 60% identify as white, 13% as 
African-American or Black, 18% as Hispanic, and 2% as 
another race or ethnicity.3 Conversations about civil rights 
often fail to include people who identify as transgender 
or gender nonconforming. Binary systems are often used 
when thinking about categories like sex, gender, and 
sexual orientation, meaning that there are 2 dichotomous 
categories for each. Transgender people fall into a third 
category; their “gender identity and/or gender role [does] 
not conform to what is typically associated with their sex 
assigned at birth.”4 
Although most oral health professionals have probably 
met a transgender person, they may remain oblivious to 
understanding who these people are, what issues they face, 
and how oral health care providers can support or deliver 
much needed health services in a respectful and intelligent 
manner. Oral health professionals have a responsibility to 
render nonbiased, nonprejudicial care to all of their clients 
and must therefore have a thorough understanding of the 
needs and concerns of all population groups including 
transgender individuals. The purpose of this narrative 
review is to examine the most current evidence on the care 
of transgender individuals along with their general and 
oral health needs. 
METHODS
A search of the literature was conducted in the following 
databases: PubMed, Google Scholar, EBSCO Host, 
Science Direct, and Wiley Online Library using the 
keywords “transgender identity, gender non-conforming, 
discrimination, transition, binary systems, transgender oral 
cavity, transgender, transgender oral health, transgender 
dental health.” Articles published from 2000 to 2017 in 
both peer-reviewed and non-peer reviewed journals, which 
reported information regarding the oral health status of 
transgender populations, were selected for review. 
RESULTS
The search produced a total of 18 articles, 7 of which 
pertained to the oral health of transgender client 
populations. Of these 7 articles, two were related to 
transgender oral health status/treatment and were 
published in peer-reviewed journals.1,5 An article related 
to transgender oral health status/treatment was also 
found in a non-peer reviewed dental hygiene publication.6 
Additionally, 5 manuscripts were related to the education 
(or, more accurately, lack of education) of students in 
dental and dental hygiene programs on the topic of 
transgender clients. However, only 3 provided information 
pertinent to this review.7-9 One manuscript discussed the 
education being offered to students at medical schools 
regarding transgender health, while another discussed the 
experience of dental fear in transgender populations.10,11 
Two articles on eunuchs in India were found but were 
not included in this review because of poor study design. 
Data and information pertaining to the effects of stress 
on the periodontium, prevalence and treatment of sexually 
transmitted diseases, and disparities in health care 
availability for this population group were extrapolated 
from numerous peer-reviewed journals, US government 
publications, and the World Health Organization website 
in order to paint a picture of the health (including oral 
health) challenges that transgender populations face. 
The literature revealed that oral health care professionals 
need to be aware that: 1) gender is not binary; 2) 
identifying oneself as transgender is not a mental health 
disorder; and 3) transgender people face heightened risk of 
discrimination, violence, anxiety, depression, suicidality, 
substance abuse, and sexually transmitted diseases. In 
addition, transgender people face significant barriers 
to health care, including oral health care, because of 
their gender nonconformance. Among those barriers are 
the biases of health care providers. Stigmatizing these 
individuals could create undue stress that may affect 
the oral cavity. Oral health care providers should also 
learn about the basics of hormone therapy, which can be 
feminizing or masculinizing, in order to better understand 
the experiences of their transgender clients.
DISCUSSION 
Defining transgender often necessitates reviewing the 
meaning of the terms sex and gender.12 Binary systems 
tend to be used when thinking about categories like sex, 
gender, and sexual orientation, meaning that there are 2 
dichotomous categories for each. Sex is anatomical and 
biological, based on internal and external sex organs, 
chromosomes, and sex hormones.4 The binary categories 
for sex are male and female. Individuals born with mixed 
sex organism hormones and chromosomes are referred 
to as intersexual.4 These individuals represent a third 
category of sex that is not always recognized in North 
America. Gender is both psychological and social. It is a 
social construct; the population creates the psychological 
and social categories that align with genders.4
Gender identity is psychological and refers to a person’s 
inherent sense of being a man or woman.4 The binary 
categories for gender identity are man or woman. A third 
category would be genderqueer or transgender.4 According 
to the American Psychological Association, people in this 
third gender identity category “may think of themselves as 
both man and woman (bigender, pangender, androgyne); 
neither man nor woman (genderless, gender neutral, 
neutrois, agender); moving between genders (genderfluid); 
or embodying a third gender.”4
There is a difference between transgender people and 
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transsexual people. Transsexual people have changed their 
physical body or want to change their physical body to 
conform with a gender identity that does not match their 
sex. Transsexuals may have surgery and/or use hormones 
to effect these physical changes.4 Psychologists now 
understand that gender is not a binary construct. Because 
it is non-binary, there may be a range of gender identities 
and gender identity may not correspond to the sex of a 
person.4 Someone who does not fit into the typical binary 
systems may present with anger or confusion.
The American Psychological Association uses the term 
gender nonconforming (GNC) to denote people whose 
gender expression or gender identity differs from norms 
corresponding to their assigned birth sex.4 In addition, 
the abbreviation TGNC is used to refer to people who are 
transgender or gender nonconforming.4 Psychologists 
have recognized that stigma, prejudice, discrimination and, 
often, violence affect the health and well-being of TGNC 
people.4 Prejudicial attitudes may lead to the devaluing, 
dislike, and hatred of people whose gender identity 
and/or gender expression do not conform to their sex 
assigned at birth. Negative attitudes towards transgender 
individuals have been positively associated with males, 
religiosity, frequency of attendance at religious services, 
political designation, gender, and sexual prejudice.13,14 The 
factors negatively correlated with transprejudice are less 
knowledge about trans people, taking a human sexuality 
or gender course, and little contact with trans people.15
Discrimination includes behaviours such as assuming 
a person’s assigned sex at birth is fully aligned with that 
person’s gender identity, not using a person’s preferred 
name or pronoun, asking TGNC people inappropriate 
questions about their bodies, and making the assumption 
that psychopathology exists given a specific gender 
identity or gender expression.4 TGNC people who hold 
multiple marginalized identities are more vulnerable to 
discrimination and violence. TGNC women and people 
of colour disproportionately experience severe forms of 
violence and discrimination, including police violence, 
and are less likely to receive help from law enforcement.4
Two other concepts are important when discussing 
negative attitudes towards transgender persons: 
internalized transphobia and transmisogyny. Internalized 
transphobia occurs when TGNC people hold these negative 
attitudes about themselves and their gender identity. 
Transmisogyny refers to a simultaneous experience of 
sexism and anti‐trans prejudice directed specifically 
towards transwomen. Some people believe that trans 
people have a mental disorder, however the American 
Psychiatric Association would disagree. Psychiatrists 
have adopted the term gender dysphoria as a diagnosis 
characterized by “a marked incongruence between” a 
person’s gender assigned at birth and gender identity.16 
This diagnosis replaced the diagnosis of gender identity 
disorder (GID) in the Diagnostic and Statistical Manual 
of Mental Disorders (DSM) V.16 Having a transgender 
identity is not a mental illness; how one adapts to that 
identity is more important in the eyes of psychologists 
and psychiatrists. A summary of these various terms and 
their definitions is found in Table 1.
Health status and concerns
Literature on the oral health status of transgender client 
populations exists but is scanty.5,7-9 In contrast, in the 
medical domain there exists a large amount of information 
on the experiences and health status of transgender patient 
populations. Recognizing that health care providers have 
not historically received training in lesbian, gay, bisexual, 
transgender, queer (LGBTQ) issues during medical school 
and/or residencies, medical researchers are embarking on 
Table 1. Lesbian, gay, bisexual, transgender, and queer terminology and definitions 
Term Definition
Sex Anatomical and biological, based on internal and external sex organs, chromosomes, and sex 
hormones 
Intersexual individuals Born with mixed sex organism hormones and chromosomes 
Gender Psychological and social; it is a social construction
Gender identity Psychological; refers to a person’s inherent sense of being a man or woman
Transsexual One who has changed their physical body or wants to change their physical body to conform with a 
gender identity that does not match their sex
Gender nonconforming (GNC) One whose gender expression or gender identity differs from norms corresponding to their assigned 
birth sex
TGNC One who is transgender or gender nonconforming
Genderqueer or transgender A third category of gender identity 
Intersexual A third category of sex that is not recognized in the United States
Gender dysphoria An underlying and incessant anxiety created when an individual’s expressed or experienced gender 
is different from the one that was assigned to the person at birth
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projects that support and disseminate research regarding 
LGBTQ health disparities.10,17-20 Authors have identified 
consistent themes within the experiences of transgender 
populations that directly and negatively affect their 
health.21-23 These themes include:
• Stigmatization and discrimination: Structural 
(societal norms, environmental conditions, 
institutional laws and practices, i.e., public 
accommodation), interpersonal (rejection by one’s 
family and community), and individual (self-
orientation, anxiety) experiences of stigmatization 
have been shown to cause adverse health effects.21,22
• Violence: Approximately half of transgender 
persons experience some form of physical assault 
in their lifetime21 and report being victims of sexual 
assault; 84% have reported being verbally harassed 
due to their gender identity or expression.21 In all 
categories of violence, higher rates were reported 
among people of colour.22 Oral health professionals 
should be cognizant of this significantly higher rate 
of violence and consider screening and referring 
clients as appropriate.
• Mental health and substance abuse: Transgender 
persons report high levels of anxiety, depression, 
and suicidality; 41% of transgender persons report 
attempting suicide compared with 3.7% of the 
general population.22,23 The incidence of suicide 
attempts is directly associated with transgender 
people being more likely to participate in risky 
behaviour, such as sex work and/or drug and/or 
alcohol abuse.4,20-22 Baghaie et al. report a higher 
rate of dental caries and periodontal disease among 
those with substance abuse disorders than among 
the general population.24 More research is necessary 
in order to understand the impact of substance use 
on oral health in the transgender client.
• Access to adequate health care: Transgender 
persons report barriers in accessing health care 
such as lack of health insurance, denials of claims 
due to being transgender, and cost. High rates 
of unemployment further exacerbate difficulties 
in obtaining health insurance.20-23 However, the 
most often cited barrier to accessing health care 
is related to providers’ lack of knowledge and/or 
bias against transgender persons.20-22 Low-income 
and transgender people of colour report a higher 
frequency of discrimination when accessing 
adequate health care.20-22
Stress
The devastating frequency of discrimination in every aspect 
of life accounts for the high levels of stress experienced by 
transgender populations. Some degree of inflammation is 
natural, part of a complex response to harmful agents known 
as stressors, which is designed to repair cell injury and 
speed healing. Too much cellular inflammation, however, 
leads to detrimental tissue damage and contributes to a 
variety of conditions such asthma, rheumatoid arthritis, 
Alzheimer’s disease, Crohn’s disease, chronic pain, obesity, 
attention deficit hyperactivity disorder, migraines, heart 
disease, and periodontal disease.25-28
The American Academy of Periodontology (AAP) has 
long acknowledged stress as a risk factor for periodontal 
disease.29 Stress can also affect the oral cavity by increasing 
the risk of aphthous stomatitis,30 HSV2,31 bruxism,32 and 
temporomandibular/myofacial pain.33
Nearly half of all individuals who identify as 
transgender experience depression or some iteration of 
an anxiety disorder as a response to the discrimination, 
stigma, lack of acceptance, and abuse they face regularly.34 
Heima et al. found that transgender populations experience 
dental fear as a result of experiences of discrimination and 
maltreatment in dental care settings.11
Stress also has a secondary negative effect. Stigma, 
for example, forces ostracized individuals to avoid social 
encounters, shy away from health care professionals, 
and depend on addictive substances to help manage 
their anxiety and aloneness. Engaging in risk-taking 
behaviours, such as unsafe sex, is also an effect of stress 
among this client population, which contributes to 
negative health outcomes.35
Sexually transmitted diseases
Risky sexual behaviours, such as having unprotected 
anal intercourse, having multiple partners, and engaging 
in sex work, account for the high incidence of sexually 
transmitted infections (STI) seen in transgender 
populations.35,36 Unsafe needle practice involving injection 
of hormones and substances such as silicone to alter facial 
features and a high rate of illegal substance abuse also 
increase the risk of contracting a STI.36 Certain STIs, such 
as gonorrhea, exhibit oral manifestations which the oral 
health care professional should identify. Often, the client 
may be unaware of the presence of an STI, which increases 
the chances of infecting others and prevents the client 
from receiving necessary care and/or medication. 
Transgender people comprise approximately 
1% of all individuals with newly diagnosed human 
immunodeficiency virus (HIV) infections. The National 
HIV Surveillance System gathered data regarding HIV 
incidence in transgender populations from 45 states and 
the District of Columbia. Of 2,351 transgender people who 
were newly diagnosed with HIV in the years 2009 through 
2014, 84% were transgender women (male to female), 
15.4% were transgender men (female to male) and 0.7% 
listed a different gender identity (queer, bi-gender).36 Black 
or African-American transgender women have a higher 
percentage of confirmed HIV infection (56.3%) compared 
to whites (16.7%) and Hispanics or Latinos (16.1%).36 
Toibaro et al. reported a 43% prevalence of syphilis in their 
2008 study of 105 transgender people.37 No data regarding 
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prevalence of other STIs in transgender populations were 
located in this search.
With the evolution of highly active antiretroviral 
therapy (HAART), HIV-positive persons receiving 
treatment and living a healthy lifestyle can expect similar 
lifespans to those who are not HIV positive. However, oral 
manifestations are common in people with HIV infection. 
A brief review of these lesions and their treatment is 
provided in Table 2. However, because a few of these 
lesions are classified as “strong indicators for the presence 
of HIV infection,”38 readers are encouraged to update their 
knowledge of these lesions and HIV infection.
Data on human papillomavirus and herpes simplex 
virus are not routinely reported to the Centers for Disease 
Control and Prevention (CDC). However, in 2015 among the 
general population there were 1,526,658 cases of chlamydia 
reported, 395,216 cases of gonorrhea reported, and 23,872 
cases of syphilis (primary and secondary) reported.39
This was the second year in a row in which increases 
were seen in all 3 of these infections. Gonorrhea is 
particularly troublesome as recent studies have noted 
the development of bacterial resistance to the antibiotics 
normally used to treat it.40
Medications
Hormone therapy
Doctors utilize hormone therapy in order to feminize or 
masculinize physical features. The World Professional 
Association for Transgender Health (WPATH) recommends 
that the following criteria be met prior to initiation of 
hormone therapy41:
• Persistent, well-documented gender dysphoria
• Capacity to make a fully informed decision and to 
consent for treatment
• Age of majority in a given country (if younger, 
follow the Standards of Care outlined in section VI)
• If significant medical or mental health concerns are 
present, they must be reasonably well controlled.
Feminizing hormone therapy has a dual goal—to 
encourage the presentation of female secondary sex 
characteristics (breast development, redistribution of fat, 
changes in emotional and social behavior, and decreased 
libido) and discourage the presentation of male secondary 
sex characteristics (reduction of body mass and body hair 
except the scalp hair, reduction in perspiration and body 
odour, deepened voice, reduction of erectile function/
sperm/ejaculatory fluid/testicular size).42-44 The hormone 
therapy used to elicit these changes combines estrogen (the 
primary female sex hormone responsible for the production 
of female secondary sex characteristics) with an androgen 
blocker (to counteract the effects of androgens, the male 
sex hormones, testosterone and dihydrotestosterone) 
and sometimes a progestogen (plays a role in breast 
development, enhances libido, and skin elasticity, among 
others).45 However, the use of progestogens is based on 
anecdotal evidence (both from transgender women 
and providers) and not from scientific evidence derived 
from well-designed studies.42,43 The most frequently used 
androgen blocker in the United States is spironolactone; 
cyproterone acetate is most frequently used in Europe.45 
The primary class of estrogen used is 17-beta estradiol 
(often shortened to estradiol), which may be administered 
orally, intramuscularly or via the transdermal route.
Masculinizing hormone therapy develops male 
secondary sex characteristics and suppresses/minimizes 
female secondary sex characteristics, and is achieved 
through the use of several forms of parenteral testosterone. 
Table 3 summarizes feminizing and masculinizing hormone 
therapy medications. 
Table 2. Oral lesions seen in HIV infection
Lesion Presentation/other Treatment
Oral candidiasis Whitened, curd-like lesions that easily wipe off; most 
common oral lesion in HIV+ clients
Topical antifungal medications (nystatin, 
imidazoles)
Kaposi’s sarcoma Singular or numerous purple, red or brown blotches 
on the skin or mouth; a cancer that develops from the 
cells lining lymph or blood vessels
Medical intervention (chemotherapy and HAART) 
only, not treated by dental professionals 
Aphthous ulcer Singular or multiple painful, round ulcerations Topical corticosteroids, antibiotics, antifungal 
medications; laser ablation
Linear gingival erythema (gingivitis in HIV+ 
clients)
Bright red gingival margin up to 4 mm wide Possibly due to candida dubliniensis and, therefore, 
treatable with antifungal medications; HAART; 
oral health instruction
Periodontitis (necrotizing ulcerative 
periodontitis/necrotizing gingivostomatitis)
Etiology is aerobic and anaerobic bacteria Scale and root planing procedures; HAART
Oral hairy leukoplakia Asymptomatic; whitened mucosa on lateral borders 
of tongue with projection of filiform papillae which 
appear as “thick hairs”
Cryotherapy ablation, antiviral medication
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A comprehensive discussion of the specific risks and 
side effects of these agents is beyond the scope of this 
article, but the reader is encouraged to refer to the reference 
list for more sources of information on hormone therapy. 
Psychologically speaking, there is some low-quality 
evidence to suggest that feminizing and masculinizing 
hormone therapy improves gender dysphoria.21
Hormone levels in non-transgender people are used 
as reference ranges but are not absolute. The Standards 
of Care for the Health of Transsexual, Transgender, and 
Gender Nonconforming People, Seventh Version (SOC7) 
created by WPATH “allows physicians to tailor their 
practices based on individual patient issues, special 
physician skills or knowledge, cultural variations, lack of 
resources, and the need for harm reduction strategies.”41 
How soon physical changes are seen depends on the dose, 
route of administration, medications used, and medical 
risk profile, but changes are generally accomplished within 
2 years of initiation of hormone therapy.42 Therefore, client 
goals dictate titration levels and providers will increase 
estrogen and antiandrogens while monitoring hormone 
and safety levels (e.g., risk factors such as smoking which, 
in combination with estrogen therapy, is associated with an 
increased risk of venous thromboembolism, hyperkalemia, 
and renal function). Once the client has achieved the 
desired result, hormone levels are monitored yearly.
Research has shown that changes in the periodontal 
condition might be associated with variations in 
hormones. The AAP recognizes this effect and included the 
following in their 1999 periodontal classification system: 
puberty-associated gingivitis, menstrual cycle-associated 
gingivitis, and pregnancy-associated gingivitis.46 In 2017 
the AAP, in partnership with the European Federation of 
Periodontology, convened a group of experts to examine 
the most recent science regarding periodontal diseases. The 
group, known as the World Workshop on the Classification 
of Periodontal and Peri-implant Diseases and Conditions, 
has recently issued a new classification scheme for 
periodontal and peri-implant diseases in which the effects 
of sex steroids on the periodontium is listed as a “potential 
modifying factor of plaque‐induced gingivitis.”47
The changes caused by estrogen and progesterone 
include increased bleeding, inflammation, erythema, and 
slight increased tooth mobility.48 Estrogen deficiency 
is known to be positively correlated with osteoporosis 
in women.48Testosterone has a positive effect on bone 
metabolism, inhibits prostaglandin secretion, reduces 
interleukin 6 production (a cytokine), and enhances the 
work of fibroblasts and osteoblasts.48
CONCLUSION
This review provides a brief introduction to the challenges 
and health care needs of transgender persons. Health, 
as defined by the World Health Organization, is one of 
the fundamental rights of every human being and “is a 
state of complete physical, mental and social well-being 
and not merely the absence of disease or infirmity.”49 
Devastating levels of discrimination are experienced by 
transgender populations and contribute to myriad health 
issues, not the least of which is mental health. Due to the 
limited amount of literature on the oral health status of 
transgender populations, it may be difficult for dental 
hygienists to provide culturally competent care. As Ludwig 
and Morrison have stated, “We cannot provide evidence-
based dental care to a subset of the population, if that 
population has yet to be studied.”1 We hope this review 
inspires others in the profession to pursue original research 
in this field. 
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Oral or sublingual                           
Estradiol valerate (estrogen) Intramuscular
Estradiol cypionate (estrogen) Intramuscular
Estradiol gel (estrogen) Topical 
Estradiol patch (estrogen) Transdermal
Spironolactone (androgen blocker) Oral
Finasteride (androgen blocker) Oral
Dutasteride (androgen blocker) Oral
Cyproterone acetate (androgen 
blocker)
Oral
Goreselin (GnRH agonist) Subcutaneous





Testosterone enanthate, cypionate Subcutaneous, intramuscular
Testopel Implant
Testosterone gel, patch, cream Transdermal
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